1op9
From Proteopedia
(Difference between revisions)
Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
- | 1OP9 is a | + | 1OP9 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Camelus_dromedarius Camelus dromedarius] and [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1OP9 OCA]. |
==Reference== | ==Reference== | ||
- | + | <ref group="xtra">PMID:12917687</ref><references group="xtra"/> | |
[[Category: Camelus dromedarius]] | [[Category: Camelus dromedarius]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Lysozyme]] | [[Category: Lysozyme]] | ||
- | [[Category: Single protein]] | ||
[[Category: Archer, D B.]] | [[Category: Archer, D B.]] | ||
[[Category: Canet, D.]] | [[Category: Canet, D.]] | ||
Line 47: | Line 46: | ||
[[Category: Immunoglobulin]] | [[Category: Immunoglobulin]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 22:08:18 2009'' |
Revision as of 20:08, 17 February 2009
Complex of human lysozyme with camelid VHH HL6 antibody fragment
Template:ABSTRACT PUBMED 12917687
About this Structure
1OP9 is a 2 chains structure of sequences from Camelus dromedarius and Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Dumoulin M, Last AM, Desmyter A, Decanniere K, Canet D, Larsson G, Spencer A, Archer DB, Sasse J, Muyldermans S, Wyns L, Redfield C, Matagne A, Robinson CV, Dobson CM. A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature. 2003 Aug 14;424(6950):783-8. PMID:12917687 doi:http://dx.doi.org/10.1038/nature01870
Page seeded by OCA on Tue Feb 17 22:08:18 2009
Categories: Camelus dromedarius | Homo sapiens | Lysozyme | Archer, D B. | Canet, D. | Decanniere, K. | Desmyter, A. | Dobson, C M. | Dumoulin, M. | Larsson, G. | Last, A M. | Matagne, A. | Muyldermans, S. | Redfield, C. | Robinson, C V. | Sasse, J. | Spencer, A. | Wyns, L. | Amyloid fibril formation inhibition | Antigen-antibody complex | Immunoglobulin